IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 337 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 35 | +25.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 28 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 28 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | -96.6% | 28 | -96.0% | 0.00% | -100.0% |
| Q2 2018 | $29,000 | -3.3% | 708 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $30,000 | -18.9% | 708 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $37,000 | -22.9% | 708 | -23.5% | 0.00% | -20.0% |
| Q3 2017 | $48,000 | +9.1% | 926 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $44,000 | -13.7% | 926 | -14.9% | 0.01% | -16.7% |
| Q1 2017 | $51,000 | +59.4% | 1,088 | -8.3% | 0.01% | +50.0% |
| Q4 2016 | $32,000 | 0.0% | 1,186 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $32,000 | -3.0% | 1,186 | -18.0% | 0.00% | 0.0% |
| Q2 2016 | $33,000 | -26.7% | 1,447 | +8.6% | 0.00% | -20.0% |
| Q1 2016 | $45,000 | -6.2% | 1,332 | +68.4% | 0.01% | -44.4% |
| Q4 2015 | $48,000 | – | 791 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
| Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
| Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
| SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
| Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
| Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
| Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
| ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |